<PAGE>
As filed with the Securities and Exchange Commission on July 18, 2000
Registration No. 333-
------------------------------------------------------------------------------
------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
---------------
TRANSGENOMIC, INC.
(Exact name of Registrant as specified in its charter)
DELAWARE 3826 91-1789357
(State of (Primary standard industrial (I.R.S. employer
incorporation) classification code number) identification no.)
5600 SOUTH 42ND STREET
OMAHA, NEBRASKA 68107
(402) 738-5480
(Address, including zip code, and telephone number, including area code,
of Registrant's principal executive offices)
COLLIN J. D'SILVA
Chairman and Chief Executive Officer
5600 South 42nd Street
Omaha, Nebraska 68107
(402) 738-5480
(Name, address, including zip code, and telephone number, including
area code, of agent for service)
Please address a copy of all communications to:
STEVEN P. AMEN, ESQ. ROBERT B. WILLIAMS, ESQ.
Kutak Rock LLP Milbank, Tweed, Hadley & McCloy LLP
1650 Farnam Street One Chase Manhattan Plaza
Omaha, Nebraska 68102 New York, New York 10005
(402) 346-6000 (212) 530-5000
---------------
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: As soon
as practicable on or after the effective date of this Registration Statement.
If any of the securities being registered on this Form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities
Act of 1933, check the following box. / /
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. /X/ 333-32174
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. / /
If this Form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. / /
If delivery of the prospectus is expected to be made pursuant to Rule
344, check the following box. / /
<TABLE>
<CAPTION>
CALCULATION OF REGISTRATION FEE
-----------------------------------------------------------------------------------------------------------
Title of each class of Proposed maximum
securities to be Amount to be Proposed maximum aggregate Amount of
registered registered offering price offering price registration fee
-----------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Common Stock, par value 552,000(1) $15.00 $8,280,000 $2,186
$0.01 per share
-----------------------------------------------------------------------------------------------------------
</TABLE>
(1) Includes 72,000 shares which the Underwriters have the option to
purchase to cover over-allotments, if any.
<PAGE>
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
In accordance with General Instruction V to Form S-1 and Rule 462(b)
promulgated under the Securities Act of 1933, this Registration Statement
incorporates by reference the contents of the Registration Statement (File
No. 333-32174) filed with the Securities and Exchange Commission on March 10,
2000, as amended.
<PAGE>
EXHIBITS.
The following exhibits are filed herewith:
<TABLE>
<CAPTION>
EXHIBIT
NUMBER EXHIBIT TITLE
-------- -------------
<C> <S>
5.1 Opinion of Kutak Rock LLP
23.1 Consent of Deloitte & Touche LLP
23.2 Consent of Kutak Rock LLP (included in Exhibit 5.1)
</TABLE>
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, we have duly
caused this Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Omaha and State of
Nebraska, on the 18th day of July 2000.
TRANSGENOMIC, INC.
By: /s/ COLLIN J. D'SILVA
------------------------
Collin J. D'Silva
CHAIRMAN AND
CHIEF EXECUTIVE OFFICER
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities indicated as of the 18th day of July 2000.
<TABLE>
<CAPTION>
Signature Title
--------- -----
<S> <C>
/s/ Collin J. D'Silva Chairman of the Board, Director
---------------------------- and Chief Executive Officer
Collin J. D'Silva (Principal Executive Officer)
/s/ William P. Rasmussen Chief Financial Officer (Principal
---------------------------- Financial Officer)
William P. Rasmussen
/s/ Mitchell L. Murphy Controller
---------------------------- (Chief Accounting Officer)
Mitchell L. Murphy
/s/ Stephen F. Dwyer
---------------------------- Director
Stephen F. Dwyer
/s/ Douglas T. Gjerde
---------------------------- Director
Douglas T. Gjerde, Ph.D.
/s/ Jeffrey Sklar
---------------------------- Director
Jeffrey Sklar, M.D., Ph.D.
/s/ Roland J. Santoni
---------------------------- Director
Roland J. Santoni
/s/ Gregory J. Duman
---------------------------- Director
Gregory J. Duman
/s/ Parag Saxena
---------------------------- Director
Parag Saxena
</TABLE>
II-1
<PAGE>
<TABLE>
<CAPTION>
EXHIBIT INDEX
-------------
<C> <S>
5.1 Opinion of Kutak Rock LLP
23.1 Consent of Deloitte & Touche LLP
23.2 Consent of Kutak Rock LLP (included in Exhibit 5.1)
</TABLE>
